- Home
- ATOS vs PRE Comparison
ATOS vs PRE Comparison
Compare ATOS & PRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATOS
- PRE
- Stock Information
- Founded
- ATOS 2009
- PRE 2014
- Country
- ATOS United States
- PRE Hong Kong
- Employees
- ATOS N/A
- PRE N/A
- Industry
- ATOS Biotechnology: Pharmaceutical Preparations
- PRE Biotechnology: Laboratory Analytical Instruments
- Sector
- ATOS Health Care
- PRE Industrials
- Exchange
- ATOS Nasdaq
- PRE Nasdaq
- Market Cap
- ATOS 107.2M
- PRE 120.7M
- IPO Year
- ATOS 2012
- PRE N/A
- Fundamental
- Price
- ATOS $0.94
- PRE $7.89
- Analyst Decision
- ATOS Strong Buy
- PRE Buy
- Analyst Count
- ATOS 3
- PRE 1
- Target Price
- ATOS $6.17
- PRE $9.00
- AVG Volume (30 Days)
- ATOS 1.5M
- PRE 83.8K
- Earning Date
- ATOS 08-11-2025
- PRE 07-22-2025
- Dividend Yield
- ATOS N/A
- PRE N/A
- EPS Growth
- ATOS N/A
- PRE N/A
- EPS
- ATOS N/A
- PRE N/A
- Revenue
- ATOS N/A
- PRE $41,520,000.00
- Revenue This Year
- ATOS N/A
- PRE $148.70
- Revenue Next Year
- ATOS N/A
- PRE $82.89
- P/E Ratio
- ATOS N/A
- PRE N/A
- Revenue Growth
- ATOS N/A
- PRE 78.72
- 52 Week Low
- ATOS $0.55
- PRE $3.10
- 52 Week High
- ATOS $1.66
- PRE $11.99
- Technical
- Relative Strength Index (RSI)
- ATOS 58.44
- PRE 49.68
- Support Level
- ATOS $0.81
- PRE $7.80
- Resistance Level
- ATOS $0.88
- PRE $8.29
- Average True Range (ATR)
- ATOS 0.05
- PRE 0.72
- MACD
- ATOS 0.01
- PRE -0.09
- Stochastic Oscillator
- ATOS 84.07
- PRE 19.79
About ATOS Atossa Therapeutics Inc.
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.
About PRE Prenetics Global Limited
Prenetics Global Ltd is a health sciences company dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, a U.S. sports distribution company. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by 'enhancing life through science'.